Skip to main content
SpringerLink
Log in

Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury

  • Original Article
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Post-translational protein modifications present an elegant and energy efficient way to dynamically reprogram cellular protein properties and functions in response to homeostatic imbalance. One such protein modification is the tagging of proteins with the small modifier ubiquitin that can have an impact on protein stability, localization, interaction dynamics, and function. Ubiquitination is vital to any eukaryotic cell under physiological conditions, but even more important under stress including oxidative, genotoxic, and heat stress, where ubiquitination levels are drastically increased. Elevated levels of ubiquitin-protein conjugates are also observed in the brain after focal and global cerebral ischemia. Post-ischemic ubiquitination is immediately induced with reperfusion and transiently detected in neurons with survival potential located in the peri-infarct area. This review aims to critically discuss current knowledge and controversies on protein ubiquitination after cerebral ischemia, with special emphasis on potential mechanisms leading to elevated ubiquitination and on target identification. Further, possible functional implications of post-ischemic ubiquitination, including a relationship to SUMOylation, a neuroprotective modification, will be highlighted. The elevation in ubiquitinated proteins following cerebral ischemia is a greatly under-explored research area, the better understanding of which may contribute to the development of novel stroke therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011;44(2):325–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ciechanover A, Heller H, Elias S, Haas AL, Hershko A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc Natl Acad Sci U S A. 1980;77(3):1365–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hershko A, Eytan E, Ciechanover A, Haas AL. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins. J Biol Chem. 1982;257(23):13964–70.

    CAS  PubMed  Google Scholar 

  4. Muratani M, Tansey WP. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol. 2003;4(3):192–201.

    Article  CAS  PubMed  Google Scholar 

  5. Reed SI. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat Rev Mol Cell Biol. 2003;4(11):855–64.

    Article  CAS  PubMed  Google Scholar 

  6. Wang J, Maldonado MA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol. 2006;3(4):255–61.

    CAS  PubMed  Google Scholar 

  7. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. 2007;315(5809):201–5.

    Article  CAS  PubMed  Google Scholar 

  8. Chen ZJ, Sun LJ. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 2009;33(3):275–86.

    Article  CAS  PubMed  Google Scholar 

  9. Pickart CM, Eddins MJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta. 2004;1695(1–3):55–72.

    Article  CAS  PubMed  Google Scholar 

  10. Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc Natl Acad Sci U S A. 2004;101(32):11707–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912–34.

    Article  CAS  PubMed  Google Scholar 

  12. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123(5):773–86.

    Article  CAS  PubMed  Google Scholar 

  13. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 2006;25(20):4877–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81:203–29.

    Article  CAS  PubMed  Google Scholar 

  15. Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell. 2006;24(5):701–11.

    Article  CAS  PubMed  Google Scholar 

  16. Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, et al. Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities. Cell. 2006;127(7):1401–13.

    Article  CAS  PubMed  Google Scholar 

  17. Kim HT, Kim KP, Lledias F, Kisselev AF, Scaglione KM, Skowyra D, et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem. 2007;282(24):17375–86.

    Article  CAS  PubMed  Google Scholar 

  18. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, et al. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol. 2003;21(8):921–6.

    Article  CAS  PubMed  Google Scholar 

  19. Hicke L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol. 2001;2(3):195–201.

    Article  CAS  PubMed  Google Scholar 

  20. Johnson ES, Ma PC, Ota IM, Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem. 1995;270(29):17442–56.

    Article  CAS  PubMed  Google Scholar 

  21. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell. 2009;137(1):133–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Komander D. The emerging complexity of protein ubiquitination. Biochem Soc Trans. 2009;37(Pt 5):937–53.

    Article  CAS  PubMed  Google Scholar 

  23. Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009;10(5):466–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Tenno T, Fujiwara K, Tochio H, Iwai K, Morita EH, Hayashi H, et al. Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells. 2004;9(10):865–75.

    Article  CAS  PubMed  Google Scholar 

  25. Varadan R, Assfalg M, Haririnia A, Raasi S, Pickart C, Fushman D. Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J Biol Chem. 2004;279(8):7055–63.

    Article  CAS  PubMed  Google Scholar 

  26. Varadan R, Walker O, Pickart C, Fushman D. Structural properties of polyubiquitin chains in solution. J Mol Biol. 2002;324(4):637–47.

    Article  CAS  PubMed  Google Scholar 

  27. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, et al. Structure of 20S proteasome from yeast at 2.4 a resolution. Nature. 1997;386(6624):463–71.

    Article  CAS  PubMed  Google Scholar 

  28. Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, Yasuoka N, et al. The structure of the mammalian 20S proteasome at 2.75 a resolution. Structure. 2002;10(5):609–18.

    Article  CAS  PubMed  Google Scholar 

  29. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science. 2003;299(5605):408–11.

    Article  CAS  PubMed  Google Scholar 

  30. Wang X, Yen J, Kaiser P, Huang L. Regulation of the 26S proteasome complex during oxidative stress. Sci Signal. 2010;3(151):ra88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell. 1998;94(5):615–23.

    Article  CAS  PubMed  Google Scholar 

  32. Verma R, Oania R, Graumann J, Deshaies RJ. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell. 2004;118(1):99–110.

    Article  CAS  PubMed  Google Scholar 

  33. Verma R, Aravind L, Oania R, McDonald WH, Yates JR 3rd, Koonin EV, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science. 2002;298(5593):611–5.

    Article  CAS  PubMed  Google Scholar 

  34. Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature. 2002;419(6905):403–7.

    Article  CAS  PubMed  Google Scholar 

  35. Braun BC, Glickman M, Kraft R, Dahlmann B, Kloetzel PM, Finley D, et al. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol. 1999;1(4):221–6.

    Article  CAS  PubMed  Google Scholar 

  36. Dubiel W, Pratt G, Ferrell K, Rechsteiner M. Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem. 1992;267(31):22369–77.

    CAS  PubMed  Google Scholar 

  37. Ustrell V, Hoffman L, Pratt G, Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 2002;21(13):3516–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem. 1994;115(2):257–69.

    Article  CAS  PubMed  Google Scholar 

  39. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, Davies KJ. The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J. 2010;432(3):585–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kloetzel PM. Antigen processing by the proteasome. Nat Rev Mol Cell Biol. 2001;2(3):179–87.

    Article  CAS  PubMed  Google Scholar 

  41. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, et al. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci. 2003;23(37):11653–61.

    CAS  PubMed  Google Scholar 

  42. Orre M, Kamphuis W, Dooves S, Kooijman L, Chan ET, Kirk CJ, et al. Reactive glia show increased immunoproteasome activity in Alzheimer's disease. Brain. 2013;136(Pt 5):1415–31.

    Article  PubMed  Google Scholar 

  43. Puttaparthi K, Elliott JL. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol. 2005;196(2):441–51.

    Article  CAS  PubMed  Google Scholar 

  44. Bingol B, Wang CF, Arnott D, Cheng D, Peng J, Sheng M. Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell. 2010;140(4):567–78.

    Article  CAS  PubMed  Google Scholar 

  45. Djakovic SN, Schwarz LA, Barylko B, DeMartino GN, Patrick GN. Regulation of the proteasome by neuronal activity and calcium/calmodulin-dependent protein kinase II. J Biol Chem. 2009;284(39):26655–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Jarome TJ, Kwapis JL, Ruenzel WL, Helmstetter FJ. CaMKII, but not protein kinase a, regulates Rpt6 phosphorylation and proteasome activity during the formation of long-term memories. Front Behav Neurosci. 2013;7:115.

    PubMed  PubMed Central  Google Scholar 

  47. Lin JT, Chang WC, Chen HM, Lai HL, Chen CY, Tao MH, et al. Regulation of feedback between protein kinase a and the proteasome system worsens Huntington's disease. Mol Cell Biol. 2013;33(5):1073–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Zhang F, Hu Y, Huang P, Toleman CA, Paterson AJ, Kudlow JE. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem. 2007;282(31):22460–71.

    Article  CAS  PubMed  Google Scholar 

  49. Ishii T, Sakurai T, Usami H, Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry. 2005;44(42):13893–901.

    Article  CAS  PubMed  Google Scholar 

  50. Liu K, Paterson AJ, Zhang F, McAndrew J, Fukuchi K, Wyss JM, et al. Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J Neurochem. 2004;89(4):1044–55.

    Article  CAS  PubMed  Google Scholar 

  51. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell. 2003;115(6):715–25.

    Article  CAS  PubMed  Google Scholar 

  52. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A. 1999;96(11):6223–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Wang D, Fang C, Zong NC, Liem DA, Cadeiras M, Scruggs SB, et al. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics. 2013;12(12):3793–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Besche HC, Sha Z, Kukushkin NV, Peth A, Hock EM, Kim W, et al. Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. EMBO J. 2014;33(10):1159–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Isasa M, Katz EJ, Kim W, Yugo V, Gonzalez S, Kirkpatrick DS, et al. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Mol Cell. 2010;38(5):733–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Bianchetta MJ, Lam TT, Jones SN, Morabito MA. Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons. J Neurosci. 2011;31(33):12029–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell. 2009;136(1):123–35.

    Article  CAS  PubMed  Google Scholar 

  58. Schwarz LA, Hall BJ, Patrick GN. Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway. J Neurosci. 2010;30(49):16718–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Zemoura K, Trumpler C, Benke D. Lys-63-linked ubiquitination of gamma-aminobutyric acid (GABA), type B1, at multiple sites by the E3 ligase mind bomb-2 targets GABAB receptors to lysosomal degradation. J Biol Chem. 2016;291(41):21682–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103(2):351–61.

    Article  CAS  PubMed  Google Scholar 

  61. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell. 2004;15(4):535–48.

    Article  CAS  PubMed  Google Scholar 

  62. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001;412(6844):346–51.

    Article  CAS  PubMed  Google Scholar 

  63. Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 2009;461(7260):114–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci. 2003;6(3):231–42.

    Article  CAS  PubMed  Google Scholar 

  65. Hamilton AM, Oh WC, Vega-Ramirez H, Stein IS, Hell JW, Patrick GN, et al. Activity-dependent growth of new dendritic spines is regulated by the proteasome. Neuron. 2012;74(6):1023–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Lopez-Salon M, Alonso M, Vianna MR, Viola H. Mello e Souza T, Izquierdo I et al. the ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci. 2001;14(11):1820–6.

    Article  CAS  PubMed  Google Scholar 

  67. Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, et al. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron. 2003;40(3):595–607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Shin SM, Zhang N, Hansen J, Gerges NZ, Pak DT, Sheng M, et al. GKAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling. Nat Neurosci. 2012;15(12):1655–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Lussier MP, Nasu-Nishimura Y, Roche KW. Activity-dependent ubiquitination of the AMPA receptor subunit GluA2. J Neurosci. 2011;31(8):3077–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Jurd R, Thornton C, Wang J, Luong K, Phamluong K, Kharazia V, et al. Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner. J Biol Chem. 2008;283(1):301–10.

    Article  CAS  PubMed  Google Scholar 

  71. Saliba RS, Michels G, Jacob TC, Pangalos MN, Moss SJ. Activity-dependent ubiquitination of GABA(a) receptors regulates their accumulation at synaptic sites. J Neurosci. 2007;27(48):13341–51.

    Article  CAS  PubMed  Google Scholar 

  72. Campbell DS, Holt CE. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron. 2001;32(6):1013–26.

    Article  CAS  PubMed  Google Scholar 

  73. Watts RJ, Hoopfer ED, Luo L. Axon pruning during drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron. 2003;38(6):871–85.

    Article  CAS  PubMed  Google Scholar 

  74. Bond U, Schlesinger MJ. Ubiquitin is a heat shock protein in chicken embryo fibroblasts. Mol Cell Biol. 1985;5(5):949–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Fornace AJ Jr, Alamo I Jr, Hollander MC, Lamoreaux E. Ubiquitin mRNA is a major stress-induced transcript in mammalian cells. Nucleic Acids Res. 1989;17(3):1215–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Kaneko M, Iwase I, Yamasaki Y, Takai T, Wu Y, Kanemoto S, et al. Genome-wide identification and gene expression profiling of ubiquitin ligases for endoplasmic reticulum protein degradation. Sci Rep. 2016;6:30955.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Qian SB, McDonough H, Boellmann F, Cyr DM, Patterson C. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature. 2006;440(7083):551–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Seufert W, Jentsch S. Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J. 1990;9(2):543–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Shang F, Gong X, Taylor A. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J Biol Chem. 1997;272(37):23086–93.

    Article  CAS  PubMed  Google Scholar 

  80. Amm I, Sommer T, Wolf DH. Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system. Biochim Biophys Acta. 2014;1843(1):182–96.

    Article  CAS  PubMed  Google Scholar 

  81. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426(6968):895–9.

    Article  CAS  PubMed  Google Scholar 

  82. Pickart CM. Ubiquitin and the stress response. In: Latchman DS, editor. Stress Proteins. Berlin, Heidelberg: Springer Berlin Heidelberg; 1999. p. 133–52.

    Chapter  Google Scholar 

  83. Preston GM, Brodsky JL. The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation. Biochem J. 2017;474(4):445–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Arnason T, Ellison MJ. Stress resistance in Saccharomyces Cerevisiae is strongly correlated with assembly of a novel type of multiubiquitin chain. Mol Cell Biol. 1994;14(12):7876–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Silva GM, Finley D, Vogel C. K63 polyubiquitination is a new modulator of the oxidative stress response. Nat Struct Mol Biol. 2015;22(2):116–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Hayashi T, Takada K, Matsuda M. Changes in ubiquitin and ubiquitin-protein conjugates in the CA1 neurons after transient sublethal ischemia. Mol Chem Neuropathol. 1991;15(1):75–82.

    Article  CAS  PubMed  Google Scholar 

  87. Hayashi T, Takada K, Matsuda M. Post-transient ischemia increase in ubiquitin conjugates in the early reperfusion. Neuroreport. 1992;3(6):519–20.

    Article  CAS  PubMed  Google Scholar 

  88. Hu BR, Janelidze S, Ginsberg MD, Busto R, Perez-Pinzon M, Sick TJ, et al. Protein aggregation after focal brain ischemia and reperfusion. J Cereb Blood Flow Metab. 2001;21(7):865–75.

    Article  CAS  PubMed  Google Scholar 

  89. Hochrainer K, Jackman K, Anrather J, Iadecola C. Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion. Stroke. 2012;43(8):2229–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Gubellini P, Bisso GM, Ciofi-Luzzatto A, Fortuna S, Lorenzini P, Michalek H, et al. Ubiquitin-mediated stress response in a rat model of brain transient ischemia/hypoxia. Neurochem Res. 1997;22(1):93–100.

    Article  CAS  PubMed  Google Scholar 

  91. Vannucci SJ, Mummery R, Hawkes RB, Rider CC, Beesley PW. Hypoxia-ischemia induces a rapid elevation of ubiquitin conjugate levels and ubiquitin immunoreactivity in the immature rat brain. J Cereb Blood Flow Metab. 1998;18(4):376–85.

    Article  CAS  PubMed  Google Scholar 

  92. Hu BR, Martone ME, Jones YZ, Liu CL. Protein aggregation after transient cerebral ischemia. J Neurosci. 2000;20(9):3191–9.

    CAS  PubMed  Google Scholar 

  93. Liu CL, Martone ME, Hu BR. Protein ubiquitination in postsynaptic densities after transient cerebral ischemia. J Cereb Blood Flow Metab. 2004;24(11):1219–25.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Liu JJ, Zhao H, Sung JH, Sun GH, Steinberg GK. Hypothermia blocks ischemic changes in ubiquitin distribution and levels following stroke. Neuroreport. 2006;17(16):1691–5.

    Article  CAS  PubMed  Google Scholar 

  95. Liu C, Chen S, Kamme F, Hu BR. Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia. Neuroscience. 2005;134(1):69–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Morimoto T, Ide T, Ihara Y, Tamura A, Kirino T. Transient ischemia depletes free ubiquitin in the gerbil hippocampal CA1 neurons. Am J Pathol. 1996;148(1):249–57.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Hayashi T, Takada K, Matsuda M. Subcellular distribution of ubiquitin-protein conjugates in the hippocampus following transient ischemia. J Neurosci Res. 1992;31(3):561–4.

    Article  CAS  PubMed  Google Scholar 

  98. Iwabuchi M, Sheng H, Thompson JW, Wang L, Dubois LG, Gooden D, et al. Characterization of the ubiquitin-modified proteome regulated by transient forebrain ischemia. J Cereb Blood Flow Metab. 2014;34(3):425–32.

    Article  CAS  PubMed  Google Scholar 

  99. Kamikubo T, Hayashi T, Ohkawa K. Lack of effect of transient ischemia on ubiquitin conjugation. Neurochem Res. 1995;20(4):391–4.

    Article  CAS  PubMed  Google Scholar 

  100. Hochrainer K, Jackman K, Benakis C, Anrather J, Iadecola C. SUMO2/3 is associated with ubiquitinated protein aggregates in the mouse neocortex after middle cerebral artery occlusion. J Cereb Blood Flow Metab. 2015;35(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  101. Bedford L, Layfield R, Mayer RJ, Peng J, Xu P. Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones. Neurosci Lett. 2011;491(1):44–7.

    Article  CAS  PubMed  Google Scholar 

  102. Noga M, Hayashi T. Ubiquitin gene expression following transient forebrain ischemia. Brain Res Mol Brain Res. 1996;36(2):261–7.

    Article  CAS  PubMed  Google Scholar 

  103. Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT. Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D. Neuropharmacology. 2013;74:96–107.

    Article  CAS  PubMed  Google Scholar 

  104. Hung AY, Sung CC, Brito IL, Sheng M. Degradation of postsynaptic scaffold GKAP and regulation of dendritic spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal neurons. PLoS One. 2010;5(3):e9842.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Kato A, Rouach N, Nicoll RA, Bredt DS. Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination. Proc Natl Acad Sci U S A. 2005;102(15):5600–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Cabral-Miranda F, Nicoloso-Simoes E, Adao-Novaes J, Chiodo V, Hauswirth WW, Linden R, et al. rAAV8-733-mediated gene transfer of CHIP/stub-1 prevents hippocampal neuronal death in experimental brain ischemia. Mol Ther. 2017;25(2):392–400.

    Article  CAS  PubMed  Google Scholar 

  107. Lackovic J, Howitt J, Callaway JK, Silke J, Bartlett P, Tan SS. Differential regulation of Nedd4 ubiquitin ligases and their adaptor protein Ndfip1 in a rat model of ischemic stroke. Exp Neurol. 2012;235(1):326–35.

    Article  CAS  PubMed  Google Scholar 

  108. Howitt J, Lackovic J, Low LH, Naguib A, Macintyre A, Goh CP, et al. Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J Cell Biol. 2012;196(1):29–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Mengesdorf T, Jensen PH, Mies G, Aufenberg C, Paschen W. Down-regulation of parkin protein in transient focal cerebral ischemia: a link between stroke and degenerative disease? Proc Natl Acad Sci U S A. 2002;99(23):15042–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Tang J, Hu Z, Tan J, Yang S, Zeng L. Parkin protects against oxygen-glucose deprivation/reperfusion insult by promoting Drp1 degradation. Oxidative Med Cell Longev. 2016;2016:8474303.

    Google Scholar 

  111. Doran JF, Jackson P, Kynoch PA, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem. 1983;40(6):1542–7.

    Article  CAS  PubMed  Google Scholar 

  112. Kumar R, Jangir DK, Verma G, Shekhar S, Hanpude P, Kumar S, et al. S-nitrosylation of UCHL1 induces its structural instability and promotes alpha-synuclein aggregation. Sci Rep. 2017;7:44558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Zhang M, Cai F, Zhang S, Zhang S, Song W. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo. Sci Rep. 2014;4:7298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Liu H, Li W, Ahmad M, Miller TM, Rose ME, Poloyac SM, et al. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiol Dis. 2011;41(2):318–28.

    Article  CAS  PubMed  Google Scholar 

  115. Shen H, Sikorska M, Leblanc J, Walker PR, Liu QY. Oxidative stress regulated expression of ubiquitin carboxyl-terminal hydrolase-L1: role in cell survival. Apoptosis. 2006;11(6):1049–59.

    Article  CAS  PubMed  Google Scholar 

  116. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell. 2002;111(2):209–18.

    Article  CAS  PubMed  Google Scholar 

  117. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet. 2003;12(16):1945–58.

    Article  CAS  PubMed  Google Scholar 

  118. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010;467(7312):179–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Lee JH, Shin SK, Jiang Y, Choi WH, Hong C, Kim DE, et al. Facilitated tau degradation by USP14 aptamers via enhanced proteasome activity. Sci Rep. 2015;5:10757.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Min JW, Lu L, Freeling JL, Martin DS, Wang H. USP14 inhibitor attenuates cerebral ischemia/reperfusion-induced neuronal injury in mice. J Neurochem. 2017;140(5):826–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Asai A, Tanahashi N, Qiu JH, Saito N, Chi S, Kawahara N, et al. Selective proteasomal dysfunction in the hippocampal CA1 region after transient forebrain ischemia. J Cereb Blood Flow Metab. 2002;22(6):705–10.

    Article  PubMed  Google Scholar 

  122. Caldeira MV, Curcio M, Leal G, Salazar IL, Mele M, Santos AR, et al. Excitotoxic stimulation downregulates the ubiquitin-proteasome system through activation of NMDA receptors in cultured hippocampal neurons. Biochim Biophys Acta. 2013;1832(1):263–74.

    Article  CAS  PubMed  Google Scholar 

  123. Ge P, Luo Y, Liu CL, Hu B. Protein aggregation and proteasome dysfunction after brain ischemia. Stroke. 2007;38(12):3230–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Kamikubo T, Hayashi T. Changes in proteasome activity following transient ischemia. Neurochem Int. 1996;28(2):209–12.

    Article  CAS  PubMed  Google Scholar 

  125. Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2000;20(10):1467–73.

    Article  CAS  PubMed  Google Scholar 

  126. Saito A, Hayashi T, Okuno S, Nishi T, Chan PH. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress. J Cereb Blood Flow Metab. 2005;25(2):267–80.

    Article  CAS  PubMed  Google Scholar 

  127. Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization of the brain 26S proteasome and its interacting proteins. Front Mol Neurosci 2010;3:12.

  128. Kisselev AF, Goldberg AL. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol. 2005;398:364–78.

    Article  CAS  PubMed  Google Scholar 

  129. Aiken CT, Kaake RM, Wang X, Huang L. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics. 2011;10(5):R110 006924.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Huang Q, Wang H, Perry SW, Figueiredo-Pereira ME. Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J Biol Chem. 2013;288(17):12161–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001;276(32):30057–63.

    Article  CAS  PubMed  Google Scholar 

  132. Farout L, Mary J, Vinh J, Szweda LI, Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys. 2006;453(1):135–42.

    Article  CAS  PubMed  Google Scholar 

  133. Li Y, Luo Y, Luo T, Lu B, Wang C, Zhang Y, et al. Trehalose inhibits protein aggregation caused by transient ischemic insults through preservation of proteasome activity, not via induction of autophagy. Mol Neurobiol. 2016; https://doi.org/10.1007/s12035-016-0196-5.

  134. Liu Y, Lu L, Hettinger CL, Dong G, Zhang D, Rezvani K, et al. Ubiquilin-1 protects cells from oxidative stress and ischemic stroke caused tissue injury in mice. J Neurosci. 2014;34(8):2813–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol. 2000;18(5):538–43.

    Article  CAS  PubMed  Google Scholar 

  136. Buchan AM, Li H, Blackburn B. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation. Neuroreport. 2000;11(2):427–30.

    Article  CAS  PubMed  Google Scholar 

  137. Doeppner TR, Kaltwasser B, Kuckelkorn U, Henkelein P, Bretschneider E, Kilic E, et al. Systemic proteasome inhibition induces sustained post-stroke neurological recovery and neuroprotection via mechanisms involving reversal of peripheral immunosuppression and preservation of blood-brain-barrier integrity. Mol Neurobiol. 2016;53(9):6332–41.

    Article  CAS  PubMed  Google Scholar 

  138. Doeppner TR, Mlynarczuk-Bialy I, Kuckelkorn U, Kaltwasser B, Herz J, Hasan MR, et al. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain. 2012;135(Pt 11):3282–97.

    Article  PubMed  Google Scholar 

  139. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke. 2000;31(7):1686–93.

    Article  CAS  PubMed  Google Scholar 

  140. Williams AJ, Hale SL, Moffett JR, Dave JR, Elliott PJ, Adams J, et al. Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J Cereb Blood Flow Metab. 2003;23(1):75–87.

    Article  CAS  PubMed  Google Scholar 

  141. Zhang L, Zhang ZG, Buller B, Jiang J, Jiang Y, Zhao D, et al. Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia. Stroke. 2010;41(5):1001–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  142. Qiu JH, Asai A, Chi S, Saito N, Hamada H, Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci. 2000;20(1):259–65.

    CAS  PubMed  Google Scholar 

  143. Meller R, Thompson SJ, Lusardi TA, Ordonez AN, Ashley MD, Jessick V, et al. Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic tolerance. J Neurosci. 2008;28(1):50–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Zhang X, Yan H, Yuan Y, Gao J, Shen Z, Cheng Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy. 2013;9(9):1321–33.

    Article  CAS  PubMed  Google Scholar 

  145. Liu C, Gao Y, Barrett J, Hu B. Autophagy and protein aggregation after brain ischemia. J Neurochem. 2010;115(1):68–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Yamashita K, Eguchi Y, Kajiwara K, Ito H. Mild hypothermia ameliorates ubiquitin synthesis and prevents delayed neuronal death in the gerbil hippocampus. Stroke. 1991;22(12):1574–81.

    Article  CAS  PubMed  Google Scholar 

  147. Ide T, Takada K, Qiu JH, Saito N, Kawahara N, Asai A, et al. Ubiquitin stress response in postischemic hippocampal neurons under nontolerant and tolerant conditions. J Cereb Blood Flow Metab. 1999;19(7):750–6.

    Article  CAS  PubMed  Google Scholar 

  148. Liang J, Yao J, Wang G, Wang Y, Wang B, Ge P. Ischemic Postconditioning protects neuronal death caused by cerebral ischemia and reperfusion via attenuating protein aggregation. Int J Med Sci. 2012;9(10):923–32.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Ouyang YB, Xu L, Giffard RG. Geldanamycin treatment reduces delayed CA1 damage in mouse hippocampal organotypic cultures subjected to oxygen glucose deprivation. Neurosci Lett. 2005;380(3):229–33.

    Article  CAS  PubMed  Google Scholar 

  150. Hayashi T, Tanaka J, Kamikubo T, Takada K, Matsuda M. Increase in ubiquitin conjugates dependent on ischemic damage. Brain Res Mol Brain Res. 1993;620(1):171–3.

    CAS  Google Scholar 

  151. Velickovska V, van Breukelen F. Ubiquitylation of proteins in livers of hibernating golden-mantled ground squirrels, Spermophilus Lateralis. Cryobiology. 2007;55(3):230–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Heun P. SUMOrganization of the nucleus. Curr Opin Cell Biol. 2007;19(3):350–5.

    Article  CAS  PubMed  Google Scholar 

  153. Cubenas-Potts C, Matunis MJ. SUMO: a multifaceted modifier of chromatin structure and function. Dev Cell. 2013;24(1):1–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Ptak C, Wozniak RW. SUMO and nucleocytoplasmic transport. Adv Exp Med Biol. 2017;963:111–26.

    Article  PubMed  Google Scholar 

  155. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem. 2001;276(38):35368–74.

    Article  CAS  PubMed  Google Scholar 

  156. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem. 2001;276(24):21664–9.

    Article  CAS  PubMed  Google Scholar 

  157. Xu J, He Y, Qiang B, Yuan J, Peng X, Pan XM. A novel method for high accuracy sumoylation site prediction from protein sequences. BMC Bioinformatics. 2008;9:8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  158. Matunis MJ, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol. 1996;135(6 Pt 1):1457–70.

    Article  CAS  PubMed  Google Scholar 

  159. Kamitani T, Kito K, Nguyen HP, Fukuda-Kamitani T, Yeh ET. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem. 1998;273(18):11349–53.

    Article  CAS  PubMed  Google Scholar 

  160. Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, Lamond AI. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics. 2006;5(12):2298–310.

    Article  CAS  PubMed  Google Scholar 

  161. Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell. 2005;9(6):769–79.

    Article  CAS  PubMed  Google Scholar 

  162. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem. 2000;275(9):6252–8.

    Article  CAS  PubMed  Google Scholar 

  163. Golebiowski F, Matic I, Tatham MH, Cole C, Yin Y, Nakamura A, et al. System-wide changes to SUMO modifications in response to heat shock. Sci Signal. 2009;2(72):ra24.

    Article  PubMed  CAS  Google Scholar 

  164. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell. 2007;131(2):309–23.

    Article  CAS  PubMed  Google Scholar 

  165. Kang X, Li J, Zou Y, Yi J, Zhang H, Cao M, et al. PIASy stimulates HIF1alpha SUMOylation and negatively regulates HIF1alpha activity in response to hypoxia. Oncogene. 2010;29(41):5568–78.

    Article  CAS  PubMed  Google Scholar 

  166. Shao R, Zhang FP, Tian F, Anders Friberg P, Wang X, Sjoland H, et al. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1alpha in adult mouse brain and heart in vivo. FEBS Lett. 2004;569(1–3):293–300.

    Article  CAS  PubMed  Google Scholar 

  167. Sobko A, Ma H, Firtel RA. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev Cell. 2002;2(6):745–56.

    Article  CAS  PubMed  Google Scholar 

  168. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol. 2008;10(5):538–46.

    Article  CAS  PubMed  Google Scholar 

  169. Schimmel J, Larsen KM, Matic I, van Hagen M, Cox J, Mann M, et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics. 2008;7(11):2107–22.

    Article  CAS  PubMed  Google Scholar 

  170. Uzunova K, Gottsche K, Miteva M, Weisshaar SR, Glanemann C, Schnellhardt M, et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J Biol Chem. 2007;282(47):34167–75.

    Article  CAS  PubMed  Google Scholar 

  171. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131(3):584–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  172. Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell. 2000;101(7):753–62.

    Article  CAS  PubMed  Google Scholar 

  173. Meulmeester E, Kunze M, Hsiao HH, Urlaub H, Melchior F. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol Cell. 2008;30(5):610–9.

    Article  CAS  PubMed  Google Scholar 

  174. Aillet F, Lopitz-Otsoa F, Egana I, Hjerpe R, Fraser P, Hay RT, et al. Heterologous SUMO-2/3-ubiquitin chains optimize IkappaBalpha degradation and NF-kappaB activity. PLoS One. 2012;7(12):e51672.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Guzzo CM, Berndsen CE, Zhu J, Gupta V, Datta A, Greenberg RA, et al. RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage. Sci Signal. 2012;5(253):ra88.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  176. Peters M, Wielsch B, Boltze J. The role of SUMOylation in cerebral hypoxia and ischemia. Neurochem Int. 2017;107:66–77.

    Article  CAS  PubMed  Google Scholar 

  177. Bernstock JD, Lee YJ, Peruzzotti-Jametti L, Southall N, Johnson KR, Maric D, et al. A novel quantitative high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate neuroprotection in a model of oxygen and glucose deprivation. J Cereb Blood Flow Metab. 2016;36(2):426–41.

    Article  CAS  PubMed  Google Scholar 

  178. Cimarosti H, Ashikaga E, Jaafari N, Dearden L, Rubin P, Wilkinson KA, et al. Enhanced SUMOylation and SENP-1 protein levels following oxygen and glucose deprivation in neurones. J Cereb Blood Flow Metab. 2012;32(1):17–22.

    Article  CAS  PubMed  Google Scholar 

  179. Datwyler AL, Lattig-Tunnemann G, Yang W, Paschen W, Lee SL, Dirnagl U, et al. SUMO2/3 conjugation is an endogenous neuroprotective mechanism. J Cereb Blood Flow Metab. 2011;31(11):2152–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  180. Lee YJ, Mou Y, Maric D, Klimanis D, Auh S, Hallenbeck JM. Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. PLoS One. 2011;6(10):e25852.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  181. Yang W, Sheng H, Warner DS, Paschen W. Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation. J Cereb Blood Flow Metab. 2008;28(5):892–6.

    Article  PubMed  CAS  Google Scholar 

  182. Yang W, Sheng H, Warner DS, Paschen W. Transient global cerebral ischemia induces a massive increase in protein sumoylation. J Cereb Blood Flow Metab. 2008;28(2):269–79.

    Article  PubMed  CAS  Google Scholar 

  183. Yang W, Sheng H, Thompson JW, Zhao S, Wang L, Miao P, et al. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways. Stroke. 2014;45(4):1115–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Yang W, Thompson JW, Wang Z, Wang L, Sheng H, Foster MW, et al. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. J Proteome Res. 2012;11(2):1108–17.

    Article  CAS  PubMed  Google Scholar 

  185. Huang X, Dixit VM. Drugging the undruggables: exploring the ubiquitin system for drug development. Cell Res. 2016;26(4):484–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR-406, New York, NY, 10065, USA

    Karin Hochrainer

Authors
  1. Karin Hochrainer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Hochrainer.

Ethics declarations

Conflict of Interest

The author declares that she has no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by the author.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hochrainer, K. Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury. Transl. Stroke Res. 9, 157–173 (2018). https://doi.org/10.1007/s12975-017-0567-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-017-0567-x

Keywords

Search

Navigation